Table of Contents
- EXECUTIVE SUMMARY
- A detailed and comprehensive overview of current financial position,
company strategy, product and pipeline analysis.
- THERAPEUTIC AREA FOCUS
- Key product analysis and forecasting
- Central Nervous System
- Cipralex/Lexapro (escitalopram)
- Ebixa (memantine)
- Serdolect/Serlect (sertindole)
- Agilect/Azilect (rasagiline)
- OPERATIONAL DATA
- A wealth of background and detail
- A full 5-year financial performance assessment
- Key corporate events
- Key agreements
- Infrastructure
- Subsidiaries and joint ventures
|
Related Report
|
View Cart
